REPORT ID 8470

United States Respiratory Inhaler Market Report 2017

Publish Date
8-Nov-17
Pages
100
Format
Electronic (PDF)

In this report, the United States Respiratory Inhaler market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of Respiratory Inhaler in these regions, from 2012 to 2022 (forecast).

United States Respiratory Inhaler market competition by top manufacturers/players, with Respiratory Inhaler sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Koninklijke Philips
    Omron Healthcare
    Merck
    Cipla
    GlaxoSmithKline
    PARI Medical Holding
    Teva Pharmaceutical Industries
    AstraZeneca
    Beximco Pharmaceuticals
    Boehringer Ingelheim

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Dry Powder Inhaler
    Metered Dose Inhaler
    Nebulizer
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Hospital and Clinic
    Home Care

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

United States Respiratory Inhaler Market Report 2017
1 Respiratory Inhaler Overview
    1.1 Product Overview and Scope of Respiratory Inhaler
    1.2 Classification of Respiratory Inhaler by Product Category
        1.2.1 United States Respiratory Inhaler Market Size (Sales Volume) Comparison by Type (2012-2022)
        1.2.2 United States Respiratory Inhaler Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
        1.2.3 Dry Powder Inhaler
        1.2.4 Metered Dose Inhaler
        1.2.5 Nebulizer
    1.3 United States Respiratory Inhaler Market by Application/End Users
        1.3.1 United States Respiratory Inhaler Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
        1.3.2 Hospital and Clinic
        1.3.3 Home Care
    1.4 United States Respiratory Inhaler Market by Region
        1.4.1 United States Respiratory Inhaler Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 The West Respiratory Inhaler Status and Prospect (2012-2022)
        1.4.3 Southwest Respiratory Inhaler Status and Prospect (2012-2022)
        1.4.4 The Middle Atlantic Respiratory Inhaler Status and Prospect (2012-2022)
        1.4.5 New England Respiratory Inhaler Status and Prospect (2012-2022)
        1.4.6 The South Respiratory Inhaler Status and Prospect (2012-2022)
        1.4.7 The Midwest Respiratory Inhaler Status and Prospect (2012-2022)
    1.5 United States Market Size (Value and Volume) of Respiratory Inhaler (2012-2022)
        1.5.1 United States Respiratory Inhaler Sales and Growth Rate (2012-2022)
        1.5.2 United States Respiratory Inhaler Revenue and Growth Rate (2012-2022)

2 United States Respiratory Inhaler Market Competition by Players/Suppliers
    2.1 United States Respiratory Inhaler Sales and Market Share of Key Players/Suppliers (2012-2017)
    2.2 United States Respiratory Inhaler Revenue and Share by Players/Suppliers (2012-2017)
    2.3 United States Respiratory Inhaler Average Price by Players/Suppliers (2012-2017)
    2.4 United States Respiratory Inhaler Market Competitive Situation and Trends
        2.4.1 United States Respiratory Inhaler Market Concentration Rate
        2.4.2 United States Respiratory Inhaler Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers Respiratory Inhaler Manufacturing Base Distribution, Sales Area, Product Type

3 United States Respiratory Inhaler Sales (Volume) and Revenue (Value) by Region (2012-2017)
    3.1 United States Respiratory Inhaler Sales and Market Share by Region (2012-2017)
    3.2 United States Respiratory Inhaler Revenue and Market Share by Region (2012-2017)
    3.3 United States Respiratory Inhaler Price by Region (2012-2017)

4 United States Respiratory Inhaler Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
    4.1 United States Respiratory Inhaler Sales and Market Share by Type (Product Category) (2012-2017)
    4.2 United States Respiratory Inhaler Revenue and Market Share by Type (2012-2017)
    4.3 United States Respiratory Inhaler Price by Type (2012-2017)
    4.4 United States Respiratory Inhaler Sales Growth Rate by Type (2012-2017)

5 United States Respiratory Inhaler Sales (Volume) by Application (2012-2017)
    5.1 United States Respiratory Inhaler Sales and Market Share by Application (2012-2017)
    5.2 United States Respiratory Inhaler Sales Growth Rate by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6  United States Respiratory Inhaler Players/Suppliers Profiles and Sales Data
    6.1 Koninklijke Philips
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Respiratory Inhaler Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Koninklijke Philips Respiratory Inhaler Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Omron Healthcare
        6.2.2 Respiratory Inhaler Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Omron Healthcare Respiratory Inhaler Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Merck
        6.3.2 Respiratory Inhaler Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Merck Respiratory Inhaler Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Cipla
        6.4.2 Respiratory Inhaler Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Cipla Respiratory Inhaler Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 GlaxoSmithKline
        6.5.2 Respiratory Inhaler Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 GlaxoSmithKline Respiratory Inhaler Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 PARI Medical Holding
        6.6.2 Respiratory Inhaler Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 PARI Medical Holding Respiratory Inhaler Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Teva Pharmaceutical Industries
        6.7.2 Respiratory Inhaler Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Teva Pharmaceutical Industries Respiratory Inhaler Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 AstraZeneca
        6.8.2 Respiratory Inhaler Product Category, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 AstraZeneca Respiratory Inhaler Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Beximco Pharmaceuticals
        6.9.2 Respiratory Inhaler Product Category, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Beximco Pharmaceuticals Respiratory Inhaler Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 Boehringer Ingelheim
        6.10.2 Respiratory Inhaler Product Category, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Boehringer Ingelheim Respiratory Inhaler Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview

7 Respiratory Inhaler Manufacturing Cost Analysis
    7.1 Respiratory Inhaler Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Respiratory Inhaler

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Respiratory Inhaler Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Respiratory Inhaler Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Respiratory Inhaler Market Size (Value and Volume) Forecast (2017-2022)
    11.1 United States Respiratory Inhaler Sales Volume, Revenue Forecast (2017-2022)
    11.2 United States Respiratory Inhaler Sales Volume Forecast by Type (2017-2022)
    11.3 United States Respiratory Inhaler Sales Volume Forecast by Application (2017-2022)
    11.4 United States Respiratory Inhaler Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer